Browsing Tag
IBM
151 posts
IBM deploys agentic AI at the 90th Masters Tournament to reshape golf’s digital fan experience
IBM deploys watsonx agentic AI at the Masters Tournament, powering archive search and shot analysis. Read what it means for enterprise AI and the IBM stock thesis.
IBM seals Confluent deal: 6,500 enterprise customers and Apache Kafka’s dominant commercial stack now inside Big Blue
IBM closes $11B Confluent acquisition, adding real-time data streaming to its AI stack. What this means for enterprise AI, competitors, and IBM investors. Read more.
Bain & Company and IBM partner to bring post-quantum cryptography risk assessment into corporate dealmaking
Bain & Company and IBM launch post-quantum cryptography assessments for investors and corporates. Discover why quantum risk is entering M&A strategy.
IBM introduces quantum-centric supercomputing architecture to integrate quantum processors with classical HPC systems
IBM unveils a quantum-centric supercomputing architecture integrating quantum processors with classical HPC systems. Discover what it means for science and industry.
The sub-1nm race is heating up and IBM and Lam Research just made their move
IBM Corporation and Lam Research Corporation launch a five-year collaboration to develop sub-1nm semiconductor technology using High-NA EUV and advanced materials. Discover what this means for the future of AI chips.
Can IBM’s agentic AI strategy help SEI Investments unlock the next phase of growth?
SEI Investments Company partners with IBM to deploy agentic AI across operations. Discover how automation and data-driven workflows could reshape financial services.
Can Pasqal’s $2bn listing plan make Europe a serious quantum computing contender?
Pasqal secures €340M and plans a Nasdaq listing through a SPAC merger. Discover how the quantum computing firm plans to scale its technology globally.
Why does the Pentagon care so much about price tags? IBM’s $112m military commissary contract explained
IBM wins a $112M Defense Commissary Agency contract to modernize electronic shelf labels at 235 global military commissaries. Read the full strategic analysis.
Is AI-enabled longevity testing ready for clinical adoption? 20/20 BioLabs Inc. tests the market
Is AI-enabled longevity testing ready for clinical adoption? Explore how 20/20 BioLabs Inc. is using IBM AI to reshape preventive diagnostics.
Can the Fusemachines–ModulAIre partnership solve enterprise-scale AI deployment barriers on IBM stacks?
Find out how Fusemachines Inc. and ModulAIre plan to operationalize AI across IBM enterprise environments through their new platform partnership.